Dusquetide modulates innate immune response through binding to p62.
暂无分享,去创建一个
O. Donini | D. Logan | T. Kutateladze | Yi Zhang | Christina G. Towers | M. Håkansson | U. Singh | Jiuyang Liu | C. Towers
[1] Ying Chen,et al. p62/SQSTM1, a Central but Unexploited Target: Advances in its Physiological/Pathogenic Functions and Small Molecular Modulators. , 2020, Journal of medicinal chemistry.
[2] A. Thorburn,et al. Mechanistic insight into the regulation of SQSTM1/p62 , 2019, Autophagy.
[3] M. Komatsu,et al. p62/SQSTM1 – steering the cell through health and disease , 2018, Journal of Cell Science.
[4] A. Thorburn,et al. ZZ-dependent regulation of p62/SQSTM1 in autophagy , 2018, Nature Communications.
[5] Min Jae Lee,et al. p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis , 2017, Nature Communications.
[6] O. Donini,et al. Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients , 2017, Biotechnology reports.
[7] Z. Yun,et al. Targeting autophagy in multiple myeloma. , 2015, Leukemia research.
[8] Oreola Donini,et al. Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study. , 2016, Journal of biotechnology.
[9] M. Karin,et al. p62 in Cancer: Signaling Adaptor Beyond Autophagy , 2016, Cell.
[10] S. Subramaniam,et al. p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells. , 2016, Cancer cell.
[11] Shunsuke Takenaka,et al. A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy. , 2016, Journal of biotechnology.
[12] Wei Zhao,et al. Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation In Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones In Vivo , 2015, Leukemia.
[13] A. Ciechanover,et al. N-terminal Arginylation Targets Endoplasmic Reticulum Chaperone BiP to Autophagy Through p62 Binding , 2015, Nature Cell Biology.
[14] Christian M. Metallo,et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. , 2014, Cancer cell.
[15] A. Thorburn,et al. Sorting cells for basal and induced autophagic flux by quantitative ratiometric flow cytometry , 2014, Autophagy.
[16] Gerhard Wagner,et al. Application of iterative soft thresholding for fast reconstruction of NMR data non-uniformly sampled with multidimensional Poisson Gap scheduling , 2012, Journal of Biomolecular NMR.
[17] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[18] W. Kabsch. XDS , 2010, Acta crystallographica. Section D, Biological crystallography.
[19] L. Foster,et al. Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide* , 2009, The Journal of Biological Chemistry.
[20] Gyan Bhanot,et al. Autophagy Suppresses Tumorigenesis through Elimination of p62 , 2009, Cell.
[21] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[22] A. D'arcy,et al. An automated microseed matrix-screening method for protein crystallization. , 2007, Acta crystallographica. Section D, Biological crystallography.
[23] Oreola Donini,et al. An anti-infective peptide that selectively modulates the innate immune response , 2007, Nature Biotechnology.
[24] Kevin Cowtan,et al. The Buccaneer software for automated model building. 1. Tracing protein chains. , 2006, Acta crystallographica. Section D, Biological crystallography.
[25] M. Diaz-Meco,et al. The p62 Scaffold Regulates Nerve Growth Factor-induced NF-κB Activation by Influencing TRAF6 Polyubiquitination* , 2005, Journal of Biological Chemistry.
[26] Wayne Boucher,et al. The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.
[27] P. Barker,et al. The Atypical Protein Kinase C-interacting Protein p62 Is a Scaffold for NF-κB Activation by Nerve Growth Factor* , 2001, The Journal of Biological Chemistry.
[28] G N Murshudov,et al. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[29] K D Cowtan,et al. Density modification for macromolecular phase improvement. , 1999, Progress in biophysics and molecular biology.
[30] M. Diaz-Meco,et al. The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.
[31] Christian Griesinger,et al. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients , 1999 .
[32] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.